The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

The ubiquitin-proteasome system (UPS) is a non-lysosomal proteolytic pathway involved in numerous normal functions of the nervous ... has been implicated to a variety of neurodegenerative disorders ...

the test is able to identify early signs of Parkinson’s disease in individuals who have not yet shown clinical symptoms, potentially offering a new pathway for earlier intervention and improved ...

MANILA, Philippines — A bill to allow graduating junior high school students to pick alternative education pathways has been approved on third and final reading by the House of Representatives ...

A man fitted with a pioneering, computer-controlled brain implant to tackle his Parkinson's disease says it works so well he is sometimes able to forget he has the condition. A small computer ...

computer-controlled brain implant to tackle his Parkinson's disease says it works so well he is sometimes able to forget he has the condition. A small computer inserted into Kevin Hill's chest ...

He attributed the need to drop out to the effects of Parkinson’s disease on his playing. “It is with profound regret that, due to performance issues associated with my recently diagnosed ...

Smith, who has toured with the "Hotel California" hitmakers since 2001, is bowing out of the group for now amid a battle with Parkinson's disease. “It is with profound regret that, due to ...